FDA Drug/Biologics Approval BLA 020986 S-040, INSULIN ASPART RECOMBINANT

FDA Drug/Biologics Approval BLA 020986 S-040, INSULIN ASPART RECOMBINANT

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
BLA 020986 S-040
Company: NOVO NORDISK INC
Drug Name: NOVOLOG PENFILL
Active Ingredients: INSULIN ASPART RECOMBINANT
Strength: 300 UNITS/3ML (100 UNITS/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 06/07/2000
Marketing Status: Prescription
Submission Classification: ORIG-1
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details